Results 51 to 60 of about 3,753,947 (257)

Transcatheter Bioprosthetic Aortic Valve Dysfunction: What We Know So Far

Frontiers in Cardiovascular Medicine, 2019
Transcatheter aortic valve replacement (TAVR) is an established alternative to surgical valve replacement for patients with severe aortic stenosis (AS) and increased surgical risk.
Fadi Sawaya, Fadi Sawaya, Troels H. Jørgensen, Lars Søndergaard, Ole De Backer   +4 more
doaj   +1 more source

Structural valve deterioration does not alter tissue valves’ radiopaque landmarks: Implications for valve-in-valve therapy [PDF]

Medical Hypotheses, 2019
Valve-in-valve is established as a safe and efficient alternative to redo surgery in the treatment of structural valve deterioration (SVD). In vitro models rely on the radiopaque landmarks of undeteriorated tissue valves to establish the optimal implantation level of the transcatheter heart valves inside the deteriorated valves.
Belhaj Soulami, R., Castro, M., Haigron, P., Verhoye, J.-P.   +3 more
openaire   +3 more sources

Application of Probabilistic Neural Networks in Modelling Structural Deterioration of Stormwater Pipes [PDF]

, 2006
In Australia, when stormwater systems were first introduced over 100 years ago, they\ud were constructed independently of the sewer systems, and they are normally the responsibility\ud of the third level of government, i.e., local government or city ...
Perera, B. J. C, Tran, Dung H, Burn, Stewart, Tran, D. H, Ng, A. W. M, Davis, Paul, Davis, P, Ng, Anne WM   +7 more
core   +1 more source

Transcatheter Mitral Valve-in-Valve Implantations Using Inverted J-Valve

Frontiers in Cardiovascular Medicine, 2022
BackgroundAs bioprosthetic valves are being widely used, the incidence of structural valve deterioration increases, as well as the need for reoperation. Transcatheter mitral valve-in-valve implantations are being increasingly adopted as an alternative to
Lulu Liu, Bowen Xiao, Binggang Wu, Yingqiang Guo   +3 more
doaj   +1 more source

Younger age and valve oversizing are predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot [PDF]

, 2012
ObjectiveWe sought to identify predictors of structural valve deterioration after pulmonary valve replacement in patients with tetralogy of Fallot.MethodsA retrospective review of 227 patients with tetralogy of Fallot who underwent stented bioprosthetic ...
Christopher W. Baird, Sitaram M. Emani, Emani, Sitaram M., Sager, Maggie S., Peter C. Chen, Baird, Christopher W., David Zurakowski, John E. Mayer, del Nido, Pedro J., Mayer, John E., Chen, Peter C., Maggie S. Sager, Frank A. Pigula, Pedro J. del Nido, Pigula, Frank A., Zurakowski, David   +15 more
core   +1 more source

Apicoaortic bypass for a patient with structural valve deterioration of a 19 mm bioprosthetic valve [PDF]

Interactive CardioVascular and Thoracic Surgery, 2011
We herein report a case of apicoaortic bypass (AAB) in a 79-year old patient presenting with structural valve deterioration who had undergone an aortic valve replacement with a 19 mm bioprosthetic valve and aortocoronary (A-C) bypass grafting 4 years prior to the AAB. Considering the small diameter of the aortic annulus, the existence of a previous A-C
Satoru, Domoto, Osamu, Tagusari, Yoshitsugu, Nakamura, Yoshimasa, Seike   +3 more
openaire   +2 more sources

Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry. [PDF]

EuroIntervention
International audienceBackground: Valve durability is a key consideration as the patient population eligible for transcatheter aortic valve implantation (TAVI) expands to include lower-risk and younger individuals who are expected to live many years ...
Giannini C, Capodanno D, Toth GG, Windecker S, Schüpke S, Blackman DJ, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli AL, Schmidt A, De Backer O, Gilard M, Curtis E, L'Official G, Donal E, Laroche C, Prendergast B, Petronio AS, The European Valve Durability Tavi Registry Investigators OB.   +20 more
europepmc   +2 more sources

Transcatheter “valve-in-valve” implantation of bioprosthesis in failed surgical tricuspid bioprosthesis (first experience in Russia)

Российский кардиологический журнал, 2019
Aim. In the issue we report first in Russia experience of transcatheter “valve-invalve” implantation (TVIV) for treatment of severe tricuspid stenosis due to the structural deterioration of surgical tricuspid bioprosthesis.Material and methods.
T. E. Imaev, A. E. Komlev, V. V. Romakina, P. M. Lepilin, M. I. Makeev, A. S. Kolegaev, A. A. Margolina, O. V. Sapelnikov, I. S. Fedotenkov, M. A. Saidova, R. S. Akchurin   +10 more
doaj   +1 more source

Long‐Term Durability of Transcatheter Aortic Valve Prostheses in Patients With Bicuspid Versus Tricuspid Aortic Valve

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Currently, there is a lack of evidence for the long‐term bioprosthetic valve durability of patients with bicuspid aortic valve (BAV) following transcatheter aortic valve replacement (TAVR).
Hong‐De Li, Wei‐Ya Li, Jun‐Li Li, Shi‐Qin Peng, Yuan Feng, Yong Peng, Jia‐Fu Wei, Zhen‐Gang Zhao, Tian‐Yuan Xiong, Yuan‐Wei Xiang Ou, Yan Wang, Qing Li, Hao‐Ran Yang, Cheng‐Xiang Song, Yi‐Jun Yao, Zhong‐Kai Zhu, Qi Liu, Xi Wang, Mao Chen   +18 more
doaj   +1 more source

Hemodynamic and Clinical Outcomes in Redo-Surgical Aortic Valve Replacement vs. Transcatheter Valve-in-Valve

Structural Heart, 2022
Background: Transcatheter valve-in-valve replacement (ViV-TAVR) has emerged as an alternative to redo-surgical aortic valve replacement (Redo-SAVR) for the treatment of failed surgical aortic bioprostheses.
Sébastien Hecht, MSc, Anne-Sophie Zenses, PhD, Jérémy Bernard, MSc, Lionel Tastet, MSc, Nancy Côté, PhD, Leonardo de Freitas Campos Guimarães, MD, Jean-Michel Paradis, MD, Jonathan Beaudoin, MD, Kim O’Connor, MD, Mathieu Bernier, MD, Eric Dumont, MD, Dimitri Kalavrouziotis, MD, Robert Delarochellière, MD, Siamak Mohammadi, MD, Marie-Annick Clavel, DVM, PhD, Josep Rodés-Cabau, MD, Erwan Salaun, MD, PhD, Philippe Pibarot, DVM, PhD   +17 more
doaj   +1 more source